Aligos Therapeutics (ALGS) Capital Leases (2019 - 2025)
Aligos Therapeutics (ALGS) reported Capital Leases of $122000.0 for Q3 2025, down 35.11% on a YoY basis from $188000.0 in Q3 2024, and little changed quarter-over-quarter from $122000.0 in Q2 2025.
Aligos Therapeutics (ALGS) Capital Leases (2019 - 2025) Analysis & Trends
Aligos Therapeutics has reported Capital Leases for 7 years, with the latest figure at $122000.0 in Q3 2025.
- For the quarter ending Q3 2025, Capital Leases fell 35.11% year-over-year to $122000.0; the trailing twelve-month figure through Sep 2025 stood at $122000.0 (down 35.11% YoY), and the FY2024 full-year result was $122000.0, down 47.19% from the prior year.
- Capital Leases for Q3 2025 stood at $122000.0, roughly flat from $122000.0 in the prior quarter.
- The five-year high for Capital Leases was $261000.0 in Q4 2021, with the low at $53000.0 in Q3 2021.
- Historically, Capital Leases has averaged $175421.1 across 5 years, with a median of $188000.0 in 2023.
- Annual changes were most pronounced in 2021 — Capital Leases slumped 59.23% — and 2022, when it soared 228.3%.
- Aligos Therapeutics' Capital Leases stood at $261000.0 in 2021, then declined by 11.88% to $230000.0 in 2022, then climbed by 0.43% to $231000.0 in 2023, then slumped by 47.19% to $122000.0 in 2024, then changed by 0.0% to $122000.0 in 2025.
- The last three Capital Leases figures came in at $122000.0 (Q3 2025), $122000.0 (Q2 2025), and $122000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Aligos Therapeutics | 54.72 Mn | -25.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 122,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Dec 31, 2024 | 122,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 203,000.00 |
| Mar 31, 2024 | 217,000.00 |
| Dec 31, 2023 | 231,000.00 |
| Sep 30, 2023 | 188,000.00 |
| Jun 30, 2023 | 203,000.00 |
| Mar 31, 2023 | 205,000.00 |
| Dec 31, 2022 | 230,000.00 |
| Sep 30, 2022 | 174,000.00 |
| Jun 30, 2022 | 201,000.00 |
| Mar 31, 2022 | 231,000.00 |
| Dec 31, 2021 | 261,000.00 |
| Sep 30, 2021 | 53,000.00 |
| Jun 30, 2021 | 130,000.00 |
| Mar 31, 2021 | 130,000.00 |
| Dec 31, 2020 | 130,000.00 |